BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22328024)

  • 1. Assessment of bioburden on human and animal tissues: part 2--results of testing of human tissue and qualification of a composite sample for routine bioburden determination.
    Kowalski JB; Merritt K; Gocke D; Osborne J
    Cell Tissue Bank; 2012 Aug; 13(3):431-9. PubMed ID: 22328024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Swab or biopsy samples for bioburden testing of allograft musculoskeletal tissue?
    Varettas K
    Cell Tissue Bank; 2014 Dec; 15(4):613-8. PubMed ID: 24599706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bioburden on human and animal tissues: Part 1--results of method development and validation studies.
    Kowalski JB; Mosley GA; Merritt K; Osborne J
    Cell Tissue Bank; 2012 Mar; 13(1):129-38. PubMed ID: 21221820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disinfection of human musculoskeletal allografts in tissue banking: a systematic review.
    Mohr J; Germain M; Winters M; Fraser S; Duong A; Garibaldi A; Simunovic N; Alsop D; Dao D; Bessemer R; Ayeni OR;
    Cell Tissue Bank; 2016 Dec; 17(4):573-584. PubMed ID: 27665294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of two types of swabs for sampling allograft musculoskeletal tissue.
    Varettas K
    ANZ J Surg; 2015 Jan; 85(1-2):33-7. PubMed ID: 24811144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioburden in transport solutions of human cardiovascular tissues: a comparative evaluation of direct inoculation and membrane filter technique.
    Kraft L; Ribeiro VST; Wollmann LC; Suss PH; Tuon FF
    Cell Tissue Bank; 2018 Sep; 19(3):447-454. PubMed ID: 29556882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of two microbial detection methods used in aseptic processing of musculoskeletal allograft tissues.
    Dennis JA; Martinez OV; Landy DC; Malinin TI; Morris PR; Fox WP; Buck BE; Temple HT
    Cell Tissue Bank; 2011 Feb; 12(1):45-50. PubMed ID: 19806469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiological screening of post-mortem bone donors - two case reports.
    Vehmeyer SB; Bloem RM; Petit PL
    J Hosp Infect; 2001 Mar; 47(3):193-7. PubMed ID: 11247679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood and marrow cultures as indicators of bone contamination in cadaver donors.
    Martinez OV; Buck BE; Hernandez M; Malinin T
    Clin Orthop Relat Res; 2003 Apr; (409):317-24. PubMed ID: 12671517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial infection transmitted by human tissue allograft transplantation.
    Eastlund T
    Cell Tissue Bank; 2006; 7(3):147-66. PubMed ID: 16933037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of predisposing factors for contamination of bone and tendon allografts.
    Schubert T; Bigaré E; Van Isacker T; Gigi J; Delloye C; Cornu O
    Cell Tissue Bank; 2012 Aug; 13(3):421-9. PubMed ID: 22212704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broth versus solid agar culture of swab samples of cadaveric allograft musculoskeletal tissue.
    Varettas K
    Cell Tissue Bank; 2013 Dec; 14(4):627-31. PubMed ID: 23378168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The appropriateness of swab cultures for the release of human allograft tissue.
    Ronholdt CJ; Bogdansky S
    J Ind Microbiol Biotechnol; 2005 Aug; 32(8):349-54. PubMed ID: 15973533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium infections associated with musculoskeletal-tissue allografts.
    Kainer MA; Linden JV; Whaley DN; Holmes HT; Jarvis WR; Jernigan DB; Archibald LK
    N Engl J Med; 2004 Jun; 350(25):2564-71. PubMed ID: 15201413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioburden assessment of banked bone used for allografts.
    Varettas K; Taylor P
    Cell Tissue Bank; 2011 Feb; 12(1):37-43. PubMed ID: 19760122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue recovery practices and bioburden: a systematic review.
    Brubaker S; Lotherington K; Zhao J; Hamilton B; Rockl G; Duong A; Garibaldi A; Simunovic N; Alsop D; Dao D; Bessemer R; Ayeni OR;
    Cell Tissue Bank; 2016 Dec; 17(4):561-571. PubMed ID: 27761677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality management indicators for tissue banks: an operative model from the period of 2002-2007.
    Saldías M; Alvarez I; Pérez Campos H; Sánchez G; Acosta M
    Transplant Proc; 2009 Oct; 41(8):3476-80. PubMed ID: 19857775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and negative predictive value of swab cultures in musculoskeletal allograft procurement.
    Veen MR; Bloem RM; Petit PL
    Clin Orthop Relat Res; 1994 Mar; (300):259-63. PubMed ID: 8131346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial contamination of musculoskeletal allografts.
    Maso A; Andollina A; Bassi A; Bertoni G; Modelli L; Quinto C; Vaccari M; Fornasari PM
    Chir Organi Mov; 2003; 88(4):345-50. PubMed ID: 15259549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial contamination in postmortem bone donors.
    Vehmeyer S; Wolkenfelt J; Deijkers R; Petit P; Brand R; Bloem R
    Acta Orthop Scand; 2002 Dec; 73(6):678-83. PubMed ID: 12553518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.